University of Utah study finds risk of age-related diseases may be higher in younger B-NHL survivors

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

University of Utah researchers found that younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older B-NHL survivors five years or more after cancer diagnosis.

These results were published in Cancer Epidemiology, Biomarkers & Prevention.

Mia Hashibe, professor in the Department of Family and Preventive Medicine at the University of Utah, director of research and practice for the Division of Public Health, and a Huntsman Cancer Institute investigator, was the study senior author. Krista Ocier, a postdoctoral researcher in the Hashibe lab, was the first author.

The authors previously established that younger NHL survivors have higher relative risk of specific heart and artery diseases than their older counterparts. In the present study, they evaluated the long-term risk of respiratory, renal, and other diseases related to aging among younger versus older NHL survivors.

The study included data from 2,129 B-NHL survivors from the Utah Cancer Registry diagnosed between 1997 and 2015. Using the Utah Population Database, the authors matched up to five

cancer-free individuals from the general population (8,969 individuals in total) with each B-NHL survivor based on sex, age, and state of birth.

They identified age-related disease outcomes through medical records from Intermountain Healthcare and the University of Utah, along with statewide health care facility data, and estimated the relative risk of these outcomes for younger and older B-NHL survivors (diagnosed at less than 65 years of age or more than 65 years of age, respectively) at least five years after cancer diagnosis.

Relative risks of acute renal failure, pneumonia, and nutritional deficiency were higher among younger than older NHL survivors compared with their respective general population cohorts. Compared with the general population, the risk of acute renal failure was increased 2.24-fold in younger survivors and 1.13-fold in older survivors; the risk of pneumonia was increased 2.42-fold in younger survivors and 1.44-fold in older survivors; and the risk of nutritional deficiencies was increased 2.08-fold in younger survivors and 1.25-fold in older survivors.

The researchers did not observe risk differences for other age-related diseases such as chronic kidney disease and osteoporosis between younger and older survivors, although NHL survivors have an overall elevated risk of these diseases.

Table of Contents


President Joe Biden has announced his intent to appoint Monica Bertagnolli as the 16th director of the National Cancer Institute—and the first woman and first chair of a clinical trials cooperative group to be named to the role.The White House announcement Aug. 10 comes nearly three weeks after news of Bertagnolli’s appointment leaked out on Twitter and in the press (The Cancer Letter, July 21, 2022).
Can you imagine, as a radiation oncologist, you have to shelter your patients in a Co-60 vault to protect them from missiles, provide them with water by melting snow, feed them, keep them warm by using a backup power generator, and evacuate them just two hours before the missile destroys the radiation oncology department? 
Research shows that cancer patients who receive navigation have improved survival, access to advanced care like clinical trials, and services like genetic testing and palliative care. Navigation often results in increased screening and patients receiving treatment sooner, resulting in improved quality of life and more cancer-free days.